Clear Street’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Clear Street’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-342	Closed	-$3.66K	–	951
2023 Q4	$3.66K	Hold	342	–	–	﹤0.01%	477
2023 Q3	$3.65K	Buy	+342	New	+$3.7K	﹤0.01%	711
2022 Q4	–	Sell	-7,673	Closed	-$77K	–	1290
2022 Q3	$77K	Buy	+7,673	New	+$77.5K	﹤0.01%	232
2022 Q2	–	Sell	-853	Closed	-$9K	–	1107
2022 Q1	$9K	Buy	+853	New	+$8.62K	﹤0.01%	271

Clear Street's PBAXU Position: Q1 2024 in Review

Clear Street sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q1 2024, closing a stake of 342 shares — an estimated $3.66K sold.

Clear Street first reported a position in PBAXU in Q1 2022 and held it in 4 quarters. The position peaked at $77K in Q3 2022. 0 funds tracked by Wall St. Rank hold PBAXU as of Q1 2024.

Clear Street reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q1 2024 after selling out during the quarter.
Clear Street sold 342 Phoenix Biotech Acquisition Corp. Unit shares in Q1 2024, an estimated $3.66K.
Clear Street first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q1 2022 and held it in 4 quarters.
Clear Street's Phoenix Biotech Acquisition Corp. Unit position peaked at $77K in Q3 2022.
0 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.